|
Cardiff Lexington Corporation (CDIF) |
|
Cardiff Lexington Corporation
CDIF's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Cardiff Lexington's sales fell
by -33.07 % in II. Quarter 2024 from the same quarter a year ago.
Healthcare Facilities industry recorded
growth of revenues by 12.65 %
Cardiff Lexington faced net loss in contrast to the net income a year ago in II. Quarter 2024
• More on CDIF's Growth
|
|
Cardiff Lexington realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 0.17 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
17.81 |
PE TTM
|
|
Company's Price to Sales ratio is at 0.04.
Healthcare Facilities industry's Price to Sales ratio is at 1.31.
• More on CDIF's Valuation
|
|
|
|
|
Cardiff Lexington realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 0.17 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
17.81 |
PE TTM
|
|
Company's Price to Sales ratio is at 0.04.
Healthcare Facilities industry's Price to Sales ratio is at 1.31.
Cardiff Lexington Price to Book Ratio is at 0.08 lower than Industry Avg. of 625.18. and higher than S&P 500 Avg. of 0
• More on CDIF's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com